Alignment Healthcare, INC

Alignment Healthcare reported strong second quarter 2026 results, exceeding guidance across key metrics and raising full-year outlook.

Alignment Healthcare, Inc. held its annual stockholder meeting on June 4, 2026, where directors were elected and the appointment of Deloitte & Touche LLP was ratified.

Alignment Healthcare announced leadership changes, including the CEO assuming the Chairman role and new appointments for COO and President of MSO, to support long-term growth and operational scaling.

Alignment Healthcare's selling stockholder, General Atlantic, completed an underwritten secondary offering of 13.17 million shares of common stock, with the company receiving no proceeds.

Alignment Healthcare, Inc. reported strong fourth quarter and full-year 2025 financial results, exceeding guidance across all key metrics and raising 2026 membership and revenue outlook.

Alignment Healthcare announced robust 31% year-over-year membership growth and reaffirmed its 2025 financial guidance, projecting strong 2026 profitability.

Alignment Healthcare, Inc. announced robust Q2 2026 results, driven by significant membership growth and improved operational efficiencies, leading to a substantial increase in net income.

Alignment Healthcare, Inc. reported a significant turnaround to net income in Q3 2025, driven by robust membership growth and improved medical benefits ratio.

Alignment Healthcare, Inc. reported a significant return to net income for the second quarter and first half of 2025, driven by substantial Health Plan membership growth and an improved Medical Benefits Ratio.

Alignment Healthcare's Q1 2025 results show revenue growth and reduced net losses, alongside the announcement of a new CFO.

Alignment Healthcare's Q3 2024 results show a significant revenue increase driven by a 57.7% rise in health plan membership, despite ongoing net losses.

Alignment Healthcare's Q2 2024 results show a significant increase in revenue and membership, alongside ongoing investments in growth and technology.

Alignment Healthcare reports significant revenue and membership growth, dramatically reducing net loss and boosting Adjusted EBITDA in its 2025 annual filing.

Alignment Healthcare's 2024 10-K filing highlights a year of significant membership growth, strategic investments, and ongoing efforts to improve healthcare delivery for seniors, despite continued net losses.

Alignment Healthcare's 10-K filing highlights its mission to revolutionize senior healthcare through a consumer-centric platform, leveraging technology and data analytics.

Dawn Christine Maroney, President of Alignment Healthcare, Inc., sold 177,068 shares of common stock on July 15, 2026 for $20.83 per share.

John E Kao, Chief Executive Officer and a Director of Alignment Healthcare, Inc., sold 298,000 shares of common stock on July 10, 2026.

Alignment Healthcare, Inc. reports a transaction where EVP Joseph S. Konowiecki sold 25,000 shares of common stock.

Joseph S. Konowiecki, EVP Corporate Affairs and Director at Alignment Healthcare, Inc., reported a sale of 25,000 common shares.

Joseph S. Konowiecki, EVP of Corporate Affairs at Alignment Healthcare, Inc., reported a sale of 25,000 common shares.

Alignment Healthcare President Dawn Maroney sold 30,000 shares of common stock via a pre-arranged 10b5-1 trading plan.

Alignment Healthcare announces its 2026 Annual Meeting of Stockholders, highlighting strong 2025 financial and operational performance, including significant revenue growth and improved profitability.

Alignment Healthcare has filed a definitive proxy statement with the SEC related to its upcoming shareholder meeting.

Alignment Healthcare reports a milestone year in 2024, achieving its first full year of positive adjusted EBITDA, industry-leading membership growth, and strong revenue growth.

Alignment Healthcare has filed a definitive proxy statement with the Securities and Exchange Commission.

Alignment Healthcare's upcoming annual meeting will address key proposals including officer exculpation, director elections, and executive compensation.

Vanguard Portfolio Management has reported a beneficial ownership of 5.74% in Alignment Healthcare Inc., holding over 11.8 million shares.

Wellington Management Group LLP and its affiliates have reported beneficial ownership of 8.4% of Alignment Healthcare, Inc. common stock as of March 31, 2026.

The Vanguard Group has reported a 0% beneficial ownership in Alignment Healthcare Inc. following an internal realignment.

Wellington Management Group and its affiliates reported a 7.3% beneficial ownership stake in Alignment Healthcare, Inc. common stock as of December 31, 2025.

FMR LLC and its affiliates, including Abigail P. Johnson, reported a 7.7% beneficial ownership stake in ALIGNMENT HEALTHCARE INC as of December 31, 2025.

The Vanguard Group reported a 7.74% beneficial ownership in Alignment Healthcare Inc. common stock, totaling 15,492,802 shares, following an internal realignment.